t140-peptide and 4-benzoylphenylalanine

t140-peptide has been researched along with 4-benzoylphenylalanine* in 2 studies

Other Studies

2 other study(ies) available for t140-peptide and 4-benzoylphenylalanine

ArticleYear
Mapping the ligand-binding site on a G protein-coupled receptor (GPCR) using genetically encoded photocrosslinkers.
    Biochemistry, 2011, May-03, Volume: 50, Issue:17

    We developed a general cell-based photocrosslinking approach to investigate the binding interfaces necessary for the formation of G protein-coupled receptor (GPCR) signaling complexes. The two photoactivatable unnatural amino acids p-benzoyl-L-phenylalanine and p-azido-L-phenylalanine were incorporated by amber codon suppression technology into CXC chemokine receptor 4 (CXCR4). We then probed the ligand-binding site for the HIV-1 coreceptor blocker, T140, using a fluorescein-labeled T140 analogue. Among eight amino acid positions tested, we found a unique UV-light-dependent crosslink specifically between residue 189 and T140. These results are evaluated with molecular modeling using the crystal structure of CXCR4 bound to CVX15.

    Topics: Azides; Benzophenones; Binding Sites; Cross-Linking Reagents; Fluoresceins; Fluorescent Dyes; HEK293 Cells; HIV-1; Humans; Ligands; Models, Molecular; Mutation; Oligopeptides; Phenylalanine; Protein Binding; Receptors, CXCR4; Ultraviolet Rays

2011
Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site.
    Biochemical pharmacology, 2009, Dec-01, Volume: 78, Issue:11

    CXCR4, a G-protein-coupled receptor, which binds the chemokine stromal cell-derived factor 1 alpha (SDF-1alpha, CXCL12), is one of two co-receptors most frequently used by HIV-1 to infect CD4+ lymphocytes. The SDF-1alpha/CXCR4 axis is also involved in angiogenesis, in stem cell homing to bone marrow, in rheumatoid arthritis and in cancer. Here, we directly determined the binding site of the inverse agonist T140 on CXCR4 using photoaffinity labeling. Two T140 photoanalogs were synthesized containing the photoreactive amino acid p-benzoyl-l-phenylalanine (Bpa) in positions 5 or 10, yielding [Bpa(5)]T140 and [Bpa(10)]T140. Binding experiments on HEK293 cells stably expressing the wild-type CXCR4 receptor using 125I-SDF-1alpha demonstrated that T140 and both photoanalogs had affinities in the nanomolar range, similar to SDF-1alpha. Photolabeling led to the formation of specific, covalent 42 kDa T140-CXCR4 complexes. V8 protease digestion of both CXCR4/125I-[Bpa(5)]T140 and CXCR4/125I-[Bpa(10)]T140 adducts generated a fragment of 6kDa suggesting that the T140 photoanalogs labeled a fragment corresponding to Lys(154)-Glu(179) of the receptor's 4th transmembrane domain. Further digestion of this 6kDa fragment with endo Asp-N led to the generation of a shorter fragment validating the photolabeled region. Our results demonstrate that T140 interacts with residues of the fourth transmembrane domain of the CXCR4 receptor and provide new structural constraints enabling us to model the complex between T140 and CXCR4.

    Topics: Amino Acid Sequence; Anti-HIV Agents; Benzophenones; Binding Sites; Binding, Competitive; Cell Line; DNA, Viral; HIV-1; Humans; Iodine Radioisotopes; Models, Molecular; Molecular Sequence Data; Oligopeptides; Phenylalanine; Photoaffinity Labels; Protein Structure, Tertiary; Proviruses; Receptors, CXCR4; Structure-Activity Relationship

2009